TWD 26.9
(-1.65%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -91.01 Million TWD | -169.61% |
2022 | -33.75 Million TWD | -115.71% |
2021 | -15.64 Million TWD | -144.33% |
2020 | 35.3 Million TWD | -50.29% |
2019 | 71.01 Million TWD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -20.95 Million TWD | 37.79% |
2024 Q1 | -33.67 Million TWD | -639.37% |
2023 Q4 | 6.24 Million TWD | 116.8% |
2023 FY | -91.01 Million TWD | -169.61% |
2023 Q3 | -37.17 Million TWD | -2.75% |
2023 Q2 | -36.17 Million TWD | -51.29% |
2023 Q1 | -23.91 Million TWD | -2010.41% |
2022 FY | -33.75 Million TWD | -115.71% |
2022 Q4 | -1.13 Million TWD | 0.0% |
2021 FY | -15.64 Million TWD | -144.33% |
2020 FY | 35.3 Million TWD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Allied Biotech Corporation | 97.41 Million TWD | 193.429% |
GeneFerm Biotechnology Co., Ltd. | 124.62 Million TWD | 173.03% |
Easywell Biomedicals, Inc. | -144.81 Million TWD | 37.155% |
TTY Biopharm Company Limited | 1.12 Billion TWD | 108.065% |
Synmosa Biopharma Corporation | 594.83 Million TWD | 115.3% |
Orient EuroPharma Co., Ltd. | 143.94 Million TWD | 163.227% |
Center Laboratories, Inc. | -995.42 Million TWD | 90.857% |
Tien Liang BioTech Co., Ltd. | 17.73 Million TWD | 613.259% |
Orient Pharma Co., Ltd. | 22.28 Million TWD | 508.341% |
InnoPharmax Inc. | -70.83 Million TWD | -28.49% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 79.7 Million TWD | 214.192% |
DV Biomed Co., Ltd. | 162.91 Million TWD | 155.866% |
Foresee Pharmaceuticals Co., Ltd. | -1.03 Billion TWD | 91.218% |
Handa Pharmaceuticals, Inc. | 726.88 Million TWD | 112.521% |
UniPharma Co., Ltd. | -21.81 Million TWD | -317.233% |
Anxo Pharmaceutical Co., Ltd. | 21.86 Million TWD | 516.317% |
Alar Pharmaceuticals Inc. | 382.61 Million TWD | 123.787% |
Winston Medical Supply Co., Ltd. | 158.75 Million TWD | 157.328% |
Mercury Biopharmaceutical Corporation | -43.81 Million TWD | -107.712% |
Bioray Biotech Co., Ltd | -11.55 Million TWD | -687.36% |
TSH Biopharm Corporation Limited | 61.98 Million TWD | 246.818% |